Cardioprotective effect of rosuvastatin in vivo is dependent on inhibition of geranylgeranyl pyrophosphate and altered RhoA membrane translocation.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples